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Mutations in the retinoblastoma tumor suppressor
gene Rb are involved in many forms of human can-
cer. In this study, we investigated the early conse-
quences of inactivating Rb in the context of cellular
reprogramming. We found that Rb inactivation pro-
motes the reprogramming of differentiated cells to
a pluripotent state. Unexpectedly, this effect is cell
cycle independent, and instead reflects direct bind-
ing of Rb to pluripotency genes, including Sox2 and
Oct4, which leads to a repressed chromatin state.
More broadly, this regulation of pluripotency net-
works and Sox2 in particular is critical for the initi-
ation of tumors upon loss of Rb in mice. These
studies therefore identify Rb as a global transcrip-
tional repressor of pluripotency networks, providing
a molecular basis for previous reports about its
involvement in cell fate pliability, and implicate mis-
regulation of pluripotency factors such as Sox2 in
tumorigenesis related to loss of Rb function.
INTRODUCTION
The retinoblastoma gene product Rb is a potent suppressor of
the tumorigenic process and is genetically or functionally inacti-
vated in most, if not all, human cancers by direct mutation or al-
terations in upstream pathway members (Burkhart and Sage,
2008). Loss of Rb function has been directly implicated in initia-
tion of cancers, including retinoblastoma, osteosarcoma, and
small cell lung carcinoma in patients, as well as pituitary and thy-
roid tumors in mice (Chinnam and Goodrich, 2011). Rb controls
multiple cellular functions, including proliferation, survival, differ-entiation, metabolism, and genomic stability, but how loss of Rb
initiates cancer is still not completely understood (reviewed in
Chinnam and Goodrich, 2011; Manning and Dyson, 2012; Nico-
lay and Dyson, 2013; Viatour and Sage, 2011).
Induced pluripotent stem cells (iPSCs) and embryonic stem
cells (ESCs) share some similarities to cancer cells, including
the capacity to bypass senescence and form tumors upon trans-
plantation (Goding et al., 2014). Accordingly, some genes often
associated with cancer, such as Myc (Nakagawa et al., 2008;
Wernig et al., 2008), p53 (Krizhanovsky and Lowe, 2009), and
telomerase (Batista et al., 2011; Park et al., 2008), have been
implicated in cellular reprogramming. Additionally, two reprog-
ramming factors, Oct4 and Sox2, can be oncogenic in some
cellular contexts (Hochedlinger et al., 2005; Lu et al., 2010; Rudin
et al., 2012; Sarkar and Hochedlinger, 2013).
Given previous observations that Rb could be involved in
cellular dedifferentiation (Calo et al., 2010; McEvoy et al., 2011)
and given the similarities between reprogramming and some
aspects of tumorigenesis, we set out to identify mechanisms
by which Rb suppresses dedifferentiation using iPSC reprog-
ramming as a cellular system. We found that Rb regulates the
reprogramming of fibroblasts to iPSCs. Surprisingly, this phe-
nomenon is not due to changes in the cell cycle. Instead, Rb
globally represses pluripotency networks in somatic cells,
thereby rendering cells more amenable to reprogramming,
including in the absence of exogenous Sox2. Importantly, pitui-
tary hyperplasia driven by Rb loss in mice is blocked by Sox2
deletion, expanding the functional interaction between Rb and
Sox2 to cancer.RESULTS
Rb Loss Promotes Reprogramming to iPSCs
To test whether Rb regulates the reprogramming process, we in-
fected wild-type andRb/mouse embryonic fibroblasts (MEFs)Cell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc. 39
Figure 1. Rb Loss Removes a Block to the Cellular Reprogramming of iPSCs
(A) Reprogramming of early-passagemouse and human fibroblasts. Rb was depleted by either a germline mutation (mouse) or shRNA knockdown (human). Cells
were infected with 4F and stained for AP activity after 14 or 30 days in culture, respectively. Representative images are shown.
(B) Wells with AP+ cells and proper morphology from Oct4-GFP MEFs with lentiviral constructs expressing hairpins to Rb, p53, GFP, Luciferase, or an empty
vector (ev), subjected to the 4F (see Experimental Procedures). Significance was assessed by a t test to the 4F-infected sample (nR 3).
(C) Efficiency of iPSC formation was tested using Oct4-NeoR MEFs followed by treatment with G418 on day 15 and AP staining after 5 days of selection. Sig-
nificance was assessed by a t test to the 4F sample.
(D) Efficiency of iPSC formation was tested using cKOMEFs stained for AP activity andNanog expression to identify iPSC colonies. Significancewas assessed by
a t test (n = 3).
(E) Efficiency of iPSC formation was tested with Rb overexpression by infection with Ad-Rb-GFP or Ad-GFP. Significance was assessed by a t test (n = 2).
(F) Efficiency was tested for Rb knockdown MEFs and knockout MEFs for each of the pocket proteins. Significance was assessed by a t test to the 4F sample
(nR 3).
(G) Kinetics of reprogramming was determined by infecting shRb-infected Oct4-GFPMEFs with 4F. Plates were scored by the earliest GFP+ colony appearance
up to day 20. Significance was assessed by a t test comparing the controls against the three shRb hairpins (nR 3).
(legend continued on next page)
Cell Stem Cell
Rb Directly Regulates Pluripotency Networks
40 Cell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc.
Cell Stem Cell
Rb Directly Regulates Pluripotency Networkswith lentiviruses harboring the traditional four reprogramming
factors (4F), Oct4, Sox2, Klf4, and c-Myc. Based on the appear-
ance of alkaline phosphatase (AP)+ colonies, we saw more effi-
cient reprogramming in Rb mutant MEFs than in WT cells, sug-
gesting that loss of Rb facilitates reprogramming (Figures 1A
and 1B). A similar increase in AP+ colonies was observed with
human fibroblasts expressing shRNAs to knock down human
RB (shRB) (Figure 1A and Figure S1A available online). Because
AP is not a specific marker of pluripotency, we then used Oct4-
NeoR knockin MEFs in combination with Rb knockdown (Fig-
ure S1B) and counted neomycin-resistant colonies. To avoid
errors due to reseeding of daughter colonies, we performed a
96-well assay and quantified the wells that contained iPSC
colonies rather than the number of colonies themselves. In this
stringent assay, the reprogramming efficiency was increased in
Rb-deficient cells to a similar degree to that reported in cells
with a loss of p53 (Figures 1B and 1C) (Krizhanovsky and
Lowe, 2009). Notably, Rb loss decreased the plating efficiency
of MEFs (Figure S1C), illustrating our underestimation of the effi-
ciency of reprogramming upon Rb loss. Reprogramming was
increased by multiple hairpins against Rb (Figure 1B) upon acute
deletion of Rb in Rblox/lox conditional knockout MEFs (cKO
MEFs) after adenoviral Cre (Ad-Cre) delivery (Figure 1D) and after
treatment with 4-hydroxytamoxifen (4OHT) in Rosa26CreER cKO
MEFs (Figures S1D and S1E). Conversely, overexpression of
Rb reduced the reprogramming efficiency (Figure 1E). MEFs
deficient for p107 or p130, two factors closely related to Rb,
showed no changes in their reprogramming efficiency (Fig-
ure 1F). Triple knockout MEFs for the entire Rb family (TKOs)
did not reprogram to iPSCs, presumably due to an unidentified
stress response that leads to increased apoptosis during reprog-
ramming (Figure S1F).
To further determine the kinetics of reprogramming in the
absence of Rb, we reprogrammed Oct4-GFP knockin MEFs af-
ter Rb knockdown. Colonies re-expressing endogenous Oct4
(GFP+) appeared significantly more quickly in cells with low Rb
levels (Figure 1G). Utilizing SSEA1 expression as an early marker
of reprogramming (Brambrink et al., 2008), we observed that
Rb loss increases reprogramming as early as days 4 and 6
(Figure 1H, Figure S1G). To test the time requirement for the
exogenous factors to trigger full reprogramming, we used
Oct4-GFP;M2rtTA MEFs infected with a doxycycline (Dox)-
inducible 4F lentiviral construct. After a total of 15 days and vary-
ing the length of Dox treatment, the number of GFP+ iPSC
colonies was counted. Decreased Rb levels led to a significant
reduction in the time requirement for 4F expression to achieve
reprogramming (Figure 1I). Together, these data demonstrate
that Rb loss accelerates and enhances iPSC generation from
fibroblasts, indicating that Rb normally restricts this process.
Rb Loss Does Not Accelerate the Cell Cycle during
Reprogramming
One explanation for the increased reprogramming observed in
Rb-deficient cells is a faster cell cycle, as in p53 mutant cells(H) Analysis of early reprogramming events by SSEA1 expression in shRb (M) or
(I) Dox-dependence assay where shRb-infected Oct4-GFPMEFs were infected w
free media at regular intervals and GFP+ colonies were screened on day 15 (nR
All plots, unless noted, display the mean ± SD where *p < 0.05, **p < 0.01, and *(Hanna et al., 2009). We determined the doubling time of control
and Rb knockdown MEFs in the first 10 days of the process to
avoid the confounding effects of increased proliferation due to
enhanced reprogramming in Rb mutant cells. Notably, no signif-
icant change in the growth rate of the 4F-infected MEFs was
observed upon Rb knockdown (Figure 2A), as was previously
observed in Rb-deficient MEFs (Dannenberg et al., 2000;
Sage et al., 2000) (see below). Similarly, there was no change
in the S phase fraction in the shRb-infected MEFs, although,
at day 6 there was a trend to a longer G2 and shorter G1 (Fig-
ures 2B and 2C, Figure S2A), possibly a consequence of
increased reprogramming because a shorter G1 correlates
with the acquisition of pluripotency (Conklin and Sage, 2009).
Annexin V staining did not show a significant difference in
apoptosis (Figure 2D, Figure S2B). To quantify proliferation
specifically in reprogramming cells, we focused on SSEA1+
cells and used Carboxyfluorescein diacetate succinimidyl ester
(CFSE) pulse-chase staining to determine the number of cell
divisions after the induction of reprogramming (Koche et al.,
2011). Using an automated analysis, we confirmed that
SSEA1+ cells are proliferative (Figures S2C and S2D) and,
importantly, we found no change in the number of doublings be-
tween control and Rb knockdown populations (Figure 2E). Thus,
the enhanced reprogramming efficiency and kinetics observed
in the absence of Rb cannot be simply explained by changes
in cell cycle profiles.
Rb Binds to and Represses Pluripotency Genes
Next we sought to explore how the absence of the Rb pro-
tein might render MEFs more amenable to reprogramming.
Because Rb is a transcriptional coregulator, we determined
the consequence of Rb loss on gene expression. To this end,
cKO MEFs were infected with Ad-Cre or Ad-GFP (Figures
S3A and S3B) and infected by the 4F or an empty vector;
3 days of selection after 4F infection, the RNA was sequenced.
We used k-means clustering to divide genes that change upon
4F expression, and then we further subdivided each cluster for
changes by the further loss of Rb (Figure 3A, Figures S3C and
S3D, Table S1 available online). In all these clusters, loss of Rb
led to changes in the expression of cell cycle genes. However,
both positive (e.g., Mcm3, Pola1, and Cdk1) and negative (e.g.,
p107, Cdkn2c, and Brca1) cell cycle regulators were upregu-
lated, which may explain why loss of Rb function does not pro-
mote cell division under these conditions (Figures 3A, Figures
S3C and S3D). We used gene set enrichment analysis (GSEA)
to determine the consequences of Rb deletion on MEF or
iPSC gene sets. We found a significant enrichment for the
iPSC-specific gene signature in cells without Rb compared to
Rb wild-type cells upon 4F expression (Figure 3B and Table
S1). Interestingly, using RT-qPCR, we observed a small but sig-
nificant increase in Sox2 and Oct4 expression in Rb-deficient
MEFs even without 4F infection (Figure 3C). As expected, the
absolute expression of pluripotency genes was still much lower
(<0.5%) than in ESCs (Figure 3D). Loss of the entire Rb familycontrol (C) infected MEFs 4 and 6 days after 4F (n = 3).
ith 4F on day 0 and treated with Dox on day 1. The cells were switched to Dox-
3).
**p < 0.001. See also Figure S1.
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Figure 2. The Rb Block toward Reprogram-
ming Is Not Cell Cycle Dependent
(A) Doubling time of shRb-infected Oct4-GFP
MEFs after infection with 4F. Error bars reflect the
95% confidence interval and significance was as-
sessed using ANOVA (nR 3).
(B) Cell cycle analysis on day 4 or day 6 by PI
staining of shRb-infected Oct4-GFP MEFs in-
fected with 4F on day 0. For clarity the 4F and
4F+ev controls were combined (Con), and the
three hairpins were combined (shRb).
(C) Quantification of the cell cycle shown in (B).
Significance was assessed by a t test (n = 3).
(D) Percent apoptosis as determined by Annexin V
staining of Oct4-GFPMEFs either 4 or 6 days after
4F infection (n = 3).
(E) Number of generations (Gen) after 4F evaluated
by CFSE staining of shRb-infected MEFs. MEFs
were infected with 4F on day 0 and stained with
CFSE on day 1. On days 4 or 6, the cells were
stained with anti-SSEA1 and analyzed by FACS.
The gray curve represents CFSE-stained MEFs
grown in 0.5% serum to induce quiescence. The
black and the blue curves represent the CFSE
histogram for the SSEA1+ control or shRb sam-
ples, respectively (n = 3).
All plots display themean ± SD unless noted where
*p < 0.05. See also Figure S2.
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genes, in contrast to cell cycle genes (Figures 1D and 3C).
Slight OCT4 and SOX2 induction was also observed in human
cells in response to RB knockdown (Figure 3E). Flow cytometry
of Sox2-GFP MEFs after acute knockdown of Rb showed that42 Cell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc.the Sox2 induction observed in bulk
analysis is caused by slight induction in
many cells and not strong induction in a
few cells (Figure 3F). Thus, loss of Rb
leads to a global derepression of compo-
nents of the pluripotency transcriptional
program, leading to only a subtle gene
induction in the majority of cells.
To determine if the repressive action of
Rb on pluripotency genes might be
direct, we performedRb chromatin immu-
noprecipitation (ChIP) assays under the
same conditions as the RNA sequencing
profiling. Interrogating a few selected
genomic regions by ChIP-qPCR, we
observed that Rb binds to the promoter
regions of Sox2 and Oct4 as well as clas-
sical cell cycle genes (Figure 4A). Global
analysis of Rb ChIP sequencing data
showed that the majority of the genes
identified as being bound by Rb are asso-
ciated with the cell cycle and most are
upregulated upon loss of Rb, consistent
with its established role as a transcrip-
tional repressor (Figures S4A and S4B).
Genome-wide data also confirmed robust
Rb binding at the Sox2 and Oct4 loci (Fig-ure 4B, Table S2). Moreover, we found Rb binding to the regula-
tory regions of a number of genes involved in reprogramming
and pluripotency, an observation supported by the analysis of
human Rb ChIP sequencing data sets (Chicas et al., 2010) (Fig-
ure S4C). Remarkably, at the Sox2 locus, Rb was primarily
Figure 3. Rb Represses the Expression of
Pluripotency Factors
(A) RNA sequencing of Rblox/lox MEFs after Rb
knockout by Cre expression (C) or GFP (G)
followed by infection with an empty puromycin-
selectable lentivirus (P) or the 4F. k-means
clustering (Figures S3C and S3D) was first per-
formed to divide the genetic expression levels
that go up upon 4F expression (Cluster I), down
(Cluster III), or remain unchanged (Cluster II)
(G4F versus GP). Each of these clusters was
then further divided by whether they change af-
ter loss of Rb (G4F versus C4F). Genes of in-
terest are annotated on the left and are marked
red, blue, or black depending on whether their
expression levels go up, down, or stay un-
changed, respectively, in the C4F set (upon loss
of Rb). See also Table S1.
(B) GSEA profiles comparing the G4F and C4F
set to expression profiles of matched MEF and
iPSCs (Table S1). The green graph shows the
running enrichment score for the gene set as it is
calculated running down the genes from the RNA
sequencing (Figure 4A) that are ranked by their
enrichment in either the G4F or C4F sets (red/
blue heatmap). Normalized enrichment scores
(NESs) and false discovery rates (FDRs) for the
gene sets are reported.
(C) Gene expression in control (Con, Rb+/+;
p130+/lox; p107+/+), cKO (Rblox/lox; p130+/+;
p107+/+), and cTKO (Rblox/lox; p130lox/lox;
p107/) MEFs as assessed by RT-qPCR.
Expression is graphed as the relative expression
of Ad-Cre-infected MEFs compared to that of
Ad-GFP normalized to Arppo. Statistical signifi-
cance was determined by a paired t test of the
Ad-Cre and Ad-GFP DCt values. nd, no data.
(D) Expression measured by RT-qPCR for either
Rb cKO MEFs infected with Ad-GFP or Ad-Cre
(n = 4) or mESCs (n = 3), shown relative to
the Ad-GFP cells. Statistical significance was
determined by a paired t test of the Ad-Cre MEFs
and an unpaired t test for the mESCs.
(E) Expression measured by RT-qPCR is
graphed as the relative expression of shRB-in-
fected human fibroblasts compared to those in-
fected with an empty vector (ev) and normalized
to GAPDH. Statistical significance was determined by a paired t test of the knockdown and control DCt values; n = 2.
(F) FACS analysis of GFP in Sox2-GFP knockin MEFs after shRb infection compared to controls. Dashed line demarcates GFP+ gate.
All plots display the mean ± SD where *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S3.
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ure S4D), the active enhancer in pluripotent lineages (Tomioka
et al., 2002).
We next sought to determine if binding of Rb to pluripotency
genes might play a role in a developmental context. When we
examined expression data of both wild-type and Rb family
mutant mouse ESCs before and after differentiation into
embryoid bodies (EBs), we found a significant defect in the
silencing of pluripotency genes (listed in Figure S4C) upon differ-
entiation (Figures 4C and 4D). Additionally, Rb progressively
binds to both Oct4 and Sox2 during EB differentiation, corre-
lating with their silencing (Figure 4E). Together, these experi-
ments indicate that the binding of Rb to pluripotency factors,
including Sox2 and Oct4, may both contribute to their silencingin differentiated cells and restrict their re-expression during the
reprogramming process.
Because Rb typically requires a binding partner to be recruited
to DNA, we sought to investigate how Rb is localized to pluripo-
tency genes. Previous studies have suggested that E2F proteins
bind to Sox2 and Oct4 (Julian et al., 2013; Xu et al., 2007). To
explore if direct interactions between Rb and E2Fs at these
loci were involved in gene repression, we used MEFs in which
mutations at either the E2F-binding pocket (DG allele) or the
LxCxE-binding cleft (DL allele) were knocked in to the endoge-
nous Rb locus (Figure 4F) (Isaac et al., 2006; Talluri et al.,
2010). We found a specific increase in the reprogramming effi-
ciency of DG mutants (Figure 4G), correlating with increased
levels of Oct4 and Sox2 (Figure 4H), similar to Rb deletionCell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc. 43
Figure 4. Rb Directly Binds Regulatory Elements in the Oct4 and Sox2 Loci
(A) qPCR of Rb ChIP in Ad-GFP-infected cKO MEFs compared to Ad-Cre-infected MEFs and the mESCs as negative control. Primers are to the proximal
promoter (Table S4). Significance was assessed by an unpaired t test to the average of the Ad-Cre-infected MEFs, including the mESC sample (n = 2).
(B) Rb (blue) binding at Sox2,Oct4, andMcm7. Enrichment is shown as the log2 value of the fold change between normalized ChIP and the input samples (n = 2).
The transcription start sites (TSS) are noted.
(C) Gene expression by microarray of WT and TKOmESCs after their differentiation into embryoid bodies (n = 3). Pluripotency genes (Figure S4D) and a selection
of differentiation markers from endoderm, mesoderm, ectoderm, and trophectoderm are shown. These are also scored for their status as direct Rb targets.
(D) The average expression of the pluripotency genes shown in (C). Plots show themean (horizontal line), the 25th to the 75th percentile (box), and the extent of the
data (bars). Significance was tested by a paired t test.
(E) Rb ChIP in mESCs (d0) and after their subsequent differentiation into EBs (d3, d6, d12, and d18). Binding is shown (gray bars, left axis) as percent input
normalized to a control locus to further account for cell number. Expression from the locus (eitherOct4 or Sox2) is shown relative to the levels in the mESCs (blue
line, right axis). Significance was determined by an unpaired t test to the respective d0 values for the ChIP and qPCR sets.
(F) Schematic of Rb interaction surfaces including the general E2F binding surface (G) and the LxCxE-binding domain (L), which interacts with other silencing
factors.
(G) Reprogramming efficiency of the DG or DL mutant MEFs compared to those derived from a wild-type littermate. Efficiency was screened by AP and Nanog
staining. Significance was determined by a paired t test.
(H) Gene expression in the DG and DL MEFs compared to wild-type MEFs as assessed by RT-qPCR. Expression is graphed as the relative expression of the
mutant to the wild-type. Statistical significance was determined by a paired t test of the DCt values.
All plots, unless noted, display the mean ± SD where *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S4.
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are required for the silencing of pluripotency genes by Rb.
Rb Contributes to the Maintenance of the Chromatin
State at Pluripotency Genes in Fibroblasts
Based on these observations and the known interactions be-
tween Rb and regulators of chromatin structure (Longworth
and Dyson, 2010), we determined whether loss of Rb function
affects the chromatin at pluripotency genes. At both Oct4 and
Sox2, we observed a significant increase in the acetylation of
histone H3 (H3Ac) in the proximal promoter regions upon loss
of Rb (Figure S5A). The extent of this increase was similar to
what we observed for Rb canonical targets such as Ccna2 (Fig-
ure S5A). However, H3K4me3 was not increased at the Oct4 or
Sox2 promoter, unlike atCcna2, whichmay reflect the difference
between enhanced gene activation of an already expressed E2F
target upon Rb loss and the slight increase of basal transcription
that we observed for Oct4 and Sox2 (Figures 3C and 3D). Addi-
tionally, we found a significant loss of H3K27me3 at Oct4
(Figure S5A).
Using ChIP sequencing to gain a genome-wide perspective
on histone changes upon Rb loss, we detected significantly
increased levels of both H3Ac and H4K4me3 and a decrease
of H3K27me3 at multiple pluripotency genes, including Oct4,
Nanog, and Sox2 (Figure 5A, Figure S5B). Increased activating
marks including H3Ac and H3K4me3were highly correlated (Fig-
ure S5C) and found predominantly at cell cycle genes and known
Rb targets such as p107 (Figure 5A, Table S3); however,
increased activating marks were also observed at both Sox2
and Nanog (Figure 5A). Notably, the region with increased
H3Ac and H3K4me3 downstream of Sox2 is not the SRR2
enhancer, but rather a region that is bound by both p300 and
CTCF and can interact with the SRR2 enhancer (Dixon et al.,
2012). GSEA indicated that an iPSC-specific gene set is signifi-
cantly enriched among the genes that gain H3Ac and H3K4me3
to a similar degree as a gene set specific for Rb loss (Figure 5B).
A recent study described the existence of broad H3K4me3
domains that mark genes essential for cell identity and function
(Benayoun et al., 2014). We observed a change in broad domain
organization upon loss of Rb (Figure 5C, Figures S5D and S5E).
Strikingly, an unbiased analysis of genes that showed increased
H3K4me3 domain breadth showed that these genes were en-
riched to be direct transcriptional targets of the core pluripotency
network (e.g., OCT4 and NANOG; Table S3). The same enrich-
ment for transcriptional targets of OCT4, SOX2, KLF4, NANOG,
and TCF3 was observed in Rb-deficient cells when we analyzed
increases in H3K4me3 breadth specifically in the set of
H3K4me3-marked genes (Figure 5D). Peaks broadened by loss
of Rbwere domains more likely to be in the top 5% broadest do-
mains in mouse ESCs (Figures 5E and 5F). Thus, the absence of
Rb in MEFs generates a chromatin landscape that more closely
resembles that of an ESC. Thus, Rb loss not only leads to dere-
pression of some core pluripotency genes, but also specifically
alters the chromatin of downstream targets for these pluripo-
tency factors, possibly facilitating the transcription of a global
pluripotency program and its implementation.
The silencing of chromatin at key pluripotency genes by Rb is
consistent with the known interactions of Rb with key repressors
(Longworth and Dyson, 2010). To interrogate the recruitment ofsuch factors toOct4 and Sox2, we performed ChIP experiments
in Rb wild-type and mutant MEFs. These experiments showed
a strong correlation between cofactor recruitment and the his-
tone mark changes observed. As mentioned above, Rb loss
decreased H3K27me3 at a region spanning the distal enhancers
to the promoter of Oct4 (Figure 5A), which correlated with a
decrease of EZH2 recruitment to this region (Figure 5G). The
increased H3Ac at the proximal promoters of Oct4 and Sox2
observed in Rb mutant cells by ChIP-qPCR (Figure S5A) corre-
sponded to a significant decrease of HDAC recruitment to these
loci (Figures 5G and 5H). It should be noted, however, that the
change in H3Ac at the proximal promoters of Oct4 and Sox2
was not identified by ChIP-eq, presumably due to the low levels
of this mark escaping detection when analyzed on a genomic
scale. Finally, because p27 was reported to repress Sox2 (Li
et al., 2012), we determined p27 localization at the DNA in
wild-type, p130/; p107/, and Rb family TKO MEFs. We
found p27 binding to the downstream enhancer of Sox2 even
in the absence of p130 and p107, but not in the TKO MEFs, indi-
cating that the recruitment of p27 at the Sox2 locus can also be
mediated by Rb (Figure S5F).
Rb Functionally Regulates Oct4 and Nanog, and Its Loss
Can Functionally Replace Sox2 in Reprogramming
While the levels of derepression of pluripotency genes observed
in Rb-deficient fibroblasts are small, we wondered if they may be
sufficient to bypass the need for exogenous reprogramming fac-
tors. We infected Oct4-NeoR MEFs with three-factor combina-
tions of the reprogramming factors and a hairpin against Rb.
With just Oct4, Klf4, and c-Myc, several neomycin-resistant
clones were readily obtained in Rb knockdown cells, but not in
control cells. Fewer clones were observed with Oct4 and Klf4
alone in the Rb knockdown than with c-Myc or all four factors
(Figures S6A and S6B). No iPSC colonies were observed when
either Klf4 or Oct4 were omitted. These RbKDOKM clones, in
which the absence of Sox2 transgene was verified (Figures
S6C and S6D), had a similar morphology to that of iPSCs reprog-
rammed with the four factors and expressed endogenous
Oct4, Sox2, Nanog, and AP activity (Figure 6A). Additionally the
Rb-deficient iPSCs reprogrammed without Sox2 formed tera-
tomas with all three germ layers (Figure S6E) and contributed
to a host embryo forming chimeric mice (Figure S6F). Thus,
acute loss of Rb can functionally replace Sox2 during iPSC
reprogramming.
To determine whether Rb could control the expression of plu-
ripotency factors beyond Sox2, using another system, we tested
if Rb loss might prime Oct4 and Nanog for activation. We em-
ployed the CRISPR-on approach (Cheng et al., 2013) to directly
target the transcriptional activator VP64 to the Oct4 and Nanog
promoters and observed a significantly enhanced expression
from these genes when Rb was absent (Figure 6B). Therefore,
while Rb loss did not compensate for exogenous Oct4 to
generate fully reprogrammed iPSCs, Rb regulates theOct4 locus
physiologically.
Sox2 Is Required for the Development of Tumors
Initiated by Loss of Rb
Basedon emerging evidence thatSox2plays oncogenic roles (Lu
et al., 2010; Rudin et al., 2012), we determined if the derepressionCell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc. 45
Figure 5. Rb Loss Perturbs the Chromatin State of Pluripotency Genes by Modulating Histone Modifier Recruitment
(A) Histone modification profiles for H3Ac (light green), H3K4me3 (dark green), and H3K27me3 (red) displayed as a heatmap. The bottom track indicates regions
of significant changes for each mark by their respective color.
(B) GSEA results showing enrichment of iPSC and Rb gene sets upon gain of H3 acetylation and H3K4me3. Data shown are the rank of the gene set relative to all
identified gene sets, the normalized enrichment score (NES), and the false discovery rate (FDR).
(C) Examples of genes that show an increase (blue) or decrease (gray) in H3K4me3 domain breadth upon loss of Rb. Black bars represent the extent of the
domains.
(D) Significance for enrichment of transcription factor targets at genes that gained substantial H3K4me3 breadth in MEFs upon loss of Rb against the expected
genome-wide value from 1,000 random samplings expressed as log10 (p value) in one-sided Wilcoxon tests.
(E) Examples of a gene in which the H3K4me3 peak breadth in wild-typeMEFs (gray) is broadened upon loss of Rb (blue), compared tomESCs (green). Horizontal
black bars represent the extent of the peak.
(legend continued on next page)
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initiation. To test this idea, we crossedRosa26CreER Rblox/loxmice
toSox2lox/lox mice. As expected (Jacks et al., 1992), we observed
a significantly enlarged pituitary at 9 weeks after tamoxifen injec-
tion in Rosa26CreER Rblox/lox mice. Strikingly, concomitant loss of
Sox2 completely blocked this cancer phenotype (Figures 6C and
6D), independent of gender (Figures S6G and S6H). Accordingly,
loss of Sox2 completely inhibited cell proliferation in the pituitary
of Rb-mutant mice (Figures 6E and 6F, Figure S6I). These exper-
iments indicate that Sox2 is critical for cancer initiation upon loss
of Rb in the mouse pituitary gland.
DISCUSSION
The retinoblastoma tumor suppressor Rb is commonly inacti-
vated in human cancer. While Rb has been extensively studied,
its mechanisms of action remain incompletely understood.
Here, using iPSC reprogramming as a cellular system, we iden-
tified a new facet of Rb tumor suppressor function in which Rb
restricts the expression of pluripotency genes and their down-
stream targets, thereby preventing cellular dedifferentiation
and transformation.
The degree of Rb involvement in direct regulation of pluripo-
tency genes and downstream targets is particularly noteworthy.
Although on the individual gene level, the transcriptional changes
in pluripotency networks observed after Rb inactivation are
subtle, a sizeable number of genes are affected. The genome-
wide summation of these individually small effects results in a
global transcriptionally permissive state and could explain the
increased cell pliability of Rb-deficient cells that was observed
before (Calo et al., 2010; McEvoy et al., 2011). In fact, that low
levels of pluripotency genes, particularly Sox2, may have strong
phenotypic effects is not surprising because iPSCs often have
few genomic integrations of Sox2 proviruses (Meissner et al.,
2007; Wernig et al., 2007), and low Sox2 is in fact favorable for
high-quality iPSCs (Carey et al., 2011). Our findings also provide
a molecular basis for related cellular phenotypes directly or indi-
rectly involving Rb and previously assumed to be caused by
changes in the cell cycle (Banito et al., 2009; Li et al., 2010; Liu
et al., 2009). Notably, the effect on reprogramming was specific
for Rb and was not observed for the closely related genes p107
and p130. Much like Rb, both of these factors restrict cell cycle
progression (Dannenberg et al., 2000; Sage et al., 2000), yet are
rarely mutated in cancer. Therefore, the unique ability of Rb
among its family members to suppress dedifferentiation may
provide an explanation for its crucial role in suppressing cancer
formation while its cell cycle checkpoint role is compensated
more potently by the usually intact p107 and p130 proteins.
We found that the regulation of target genes by Rb correlates
with the recruitment of histone modifying complexes and the
subsequent regulation of histone marks. While loss of Rb re-
sulted in increases of H3Ac and H3K4me3 at cell cycle genes,(F) Fold-enrichment for overlap with top 5% broadest H3K4me3 domains (‘‘buffer
upon loss of Rb. Enrichment and significance (one-sided Wilcoxon tests) were ca
(G) ChIP-qPCR of HDAC and EZH2 in Ad-GFP- and Ad-Cre-infected MEFs plot
strength. qPCR was performed with primers to the DE, PE, proximal promoter (P
(H) ChIP-qPCR of HDAC binding shown as in Figure 5F, shown for the SRR1 and
All plots, unless noted, display the mean ± SD where *p < 0.05 and ***p < 0.001.pluripotency genes, including Oct4, Sox2, and Nanog, mostly
gained H3Ac and lost H3K27me3. This effect of Rb loss on plu-
ripotency genes therefore more likely represents a derepression
resulting in increased basal transcription rather than full activa-
tion, which is associated with robust promoter H3K4me3. While
this derepression is general to pluripotency genes, we know that
not all genes respond to the same degree because the increase
of total expression of Sox2 is markedly higher than that of Oct4,
and Rb loss could only replace Sox2 and not Oct4 to derive
iPSCs. This may be explained by additional regulatory mecha-
nisms restricting Oct4 expression, including high levels of DNA
methylation at the Oct4 locus (Mikkelsen et al., 2008), or a lack
of LIN28+ regulation of Oct4 mRNA in MEFs (Qiu et al., 2010).
Nevertheless, loss of Rb enhances the expression of both Oct4
and Nanog when forced by a strong transcriptional activator,
supporting a direct role for Rb in the regulation of these genes.
Additional evidence linking cell cycle regulators to pluripotency
genes is starting to emerge. For instance, the Cdk2 inhibitor
p27 also controls the pluripotency of ESCs by direct inhibition
of Sox2 (Li et al., 2012) (see also below). This regulation is medi-
ated by the same enhancer that we found to be bound and regu-
lated by Rb, suggesting possible interactions between p27 and
Rb on the chromatin. Future studies may elucidate whether
such interactions exist genome-wide or are specific for this
enhancer.
While we observed changes in the chromatin landscape of
MEFs after Rb loss, we expected that perturbation of the LxCxE
binding cleft would have a reprogramming phenotype similar to
loss of Rb. Mice harboring these knockin mutations have shown
defects in chromatin modifications in other settings (Bourgo
et al., 2011; Talluri et al., 2010). However, our data show that in-
teractions through this surface are not required for the silencing
of Sox2 and Oct4. This is consistent with reports that in differen-
tiated tissues,Rb-dependent silencing is normal in LxCxEmutant
mice (Andrusiak et al., 2013; Talluri et al., 2010). Furthermore, a
dominant-negative DP1 (which blocks E2F transactivation) can
rescue increased acetylation observed upon Rb loss (Andrusiak
et al., 2013). This presents two models whereby Rb might regu-
late heterochromatin. First, HDACs interact with Rb in LxCxE-in-
dependent ways, so the longstanding model of direct HDAC
recruitment is correct but at least partly LxCxE independent.
Alternatively, Rb repression of E2Fs allows HDAC recruitment
through other neighboring contacts. In this way, the effects on
chromatin are genetically Rb dependent but the biochemical
mechanism isdistinct fromsimply being recruited byRb.Regard-
less ofwhich paradigmexplains our data, E2F appears to be cen-
tral to the mechanism of Rb regulation of Sox2 and Oct4.
Regulation of Sox2 at its upstream enhancer by the Rb family/
E2F and at its downstream enhancer by p21 has already been
shown to direct the fate choices of neural stem cells (Julian
et al., 2013; Marque´s-Torrejo´n et al., 2013). We observe that
Rb represses Sox2 at its downstream, pluripotency-specificdomains’’) for genes that lost or gained substantial H3K4me3 breadth in MEFs
lculated against expected genome-wide values from 1,000 random samplings.
ted relative to the mESCs as a negative control to account for relative primer
P), and first exon (E1) of Oct4. Significance was determined by a t test.
SRR2 enhancers, the PP, and the E1 of Sox2.
See also Figure S5.
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Figure 6. Rb Regulation of Sox2 Affects the
Need for Exogenous Factors to Generate
iPSCs and Suppresses Phenotype in an Rb
Tumor Model
(A) Staining of RbKDOKM iPSCs for Oct4, Sox2,
Nanog, and AP activity. Scale bars, 100 mm, or
200 mm for AP.
(B) Oct4 and Nanog were targeted for gene acti-
vation using the CRISPR-on technique (see Sup-
plemental Experimental Procedures). RT-qPCR
was performed 5 days after Cas9-VP64 activation
and is shown relative to an rtTA-only control.
(C) Pituitaries from representative Rblox/lox;
Rosa26CreER mice for all Sox2 alleles (+, wild-type;
lx, lox/lox) 9 weeks after tamoxifen injection.
(D) Box and whisker plots of the pituitary size from
mice of the genotypes in Figure 6C, including
Rblox/lox; Rosa+/+ mice as controls.
(E) Pituitary sections of Rblox/lox; Rosa26CreER mice
that are either Sox2+/+ or Sox2lox/lox 9 weeks after
tamoxifen injection, stained with H&E (top) or Ki67
(bottom). The Pars Nervosa (PN), Pars intermedia
(PI), Pars distalis (PD), and residual cleft (rc) are
shown. The green channel was exposed equally
between the two images. Representative images
are shown.
(F) Quantification of Ki67 in Rblox/lox; Rosa26CreER
pituitaries with the shown Sox2 genotypes (+, wild-
type; lx, lox/lox) 9 weeks after tamoxifen injection.
Percentages were calculated from four pituitaries,
except the CreER control, which had n = 3.
Dashed line indicates the number of positive cells
counted in the secondary-only control.
All plots, unless noted, display the mean ± SD
where *p < 0.05, **p < 0.01, and ns = not specified.
See also Figure S6.
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sion in the pituitary induces hyperplasia in a Sox2-dependent
manner. It is noteworthy that Sox2 is expressed in the retina (Li
et al., 2012), in which loss of Rb is tumor initiating. Amplification
of Sox2 has also been shown to be a driver mutation in human
small cell lung cancer, a cancer initiated by loss of RB and p53
(Rudin et al., 2012). Although inactivation of Rb, by either muta-
tion or repression, is common to nearly all cancers, it is only initi-48 Cell Stem Cell 16, 39–50, January 8, 2015 ª2015 Elsevier Inc.ating in a few cell types. This difference
may rely in part on the initiating cell’s
ability to reactivate Sox2 transcriptional
networks. The extent by which Rb regula-
tion ofSox2 limits tumors in humans is still
unknown, but our observations support
the idea that cellular reprogramming as-
says can be used as a cellular system to
probe the molecular mechanisms of can-
cer initiation.
EXPERIMENTAL PROCEDURES
Cell Lines
The cell lines used were as follows: Rblox/lox
(cKO), Oct4-GFP+/, Oct4-Neo+/, B6;129S-
Sox2tm2Hoch/J (Sox2-GFP) and M2rtTA+/;Oct4-
GFP+/ (Brambrink et al., 2008; Burkhart et al.,2010a; Meissner et al., 2007; Wernig et al., 2007). Rb1DL/DL MEFs have been
reported previously (Isaac et al., 2006). Rb1DG/DG MEFs express an R461E,
K542E mutant and its properties have previously been reported (Cecchini
and Dick, 2011; Cecchini et al., 2014).
Reprogramming and Differentiation Assays
For the 96-well efficiency assays, shRNA-infected cells were selected by
3 days of growth in puromycin, infected with the 4F, and plated at a density
of 100 cells per well into 96-well plates containing 1,000 g-irradiated feeder
Cell Stem Cell
Rb Directly Regulates Pluripotency Networkscells per well. Wells with AP+ cells and proper morphology (after 15 days) were
reported to remove potential contribution of the seeding of daughter colonies.
EBs were formed when we plated trypsinized ESCs in nonadherent plates at a
density of 5.53 105 cells/ml in DMEMwith 10% serum. After 3 days they were
plated onto gelatin-coated tissue culture plates. After 5 days they were main-
tained in serum free conditions.
CFSE Analysis
CFSE staining was performed using the CellTrace Violet Cell Proliferation Kit
(Invitrogen #C34557). Cells were trypsinized and washed with PBS, and then
CFSE was added to 5 mM. They were incubated in the dark at 37C for
20 min and then the reaction was quenched with media for 5 min. The cells
were then washed, cultured, and later analyzed by FACS.
RNA and ChIP Sequencing
ChIP was performed as previously described (Burkhart et al., 2010b). Anti-
bodies are listed in Table S5. Sequencing libraries were generated using
the NEBNext DNA Sample Prep Master Mix Set (New England Biolabs) and
purified using Agencourt Ampure XP beads (Beckman Coulter). Library quality
was assessed on an Agilent 2100 Bioanalyzer and sequenced to generate
single-end 50 bp reads using the Illumina HiSeq platform. We analyzed
ChIP data by mapping the reads using Bowtie2 and identified peaks using
MACS2 for the histone ChIP sequencing and CisGenome for the Rb ChIP.
For expressional profiling, purified RNA was processed into cDNA with the
Ovation RNA-Seq System V2 (NuGEN) and sonicated using a Covaris S2
Sonicator. RNA sequencing data were analyzed with the Tuxedo suite.
H3K4me3 breadth remodeling was performed as previously described (Be-
nayoun et al., 2014). See Supplemental Experimental Procedures for addi-
tional information.
Pituitary Sectioning and Staining
To isolate the pituitary, we fixed the whole head overnight in Bouin’s Fixative,
removed it, fixed it overnight in 4% paraformaldehyde, and then dehydrated it
in 70% ethanol. Antigen retrieval on the sections was performed using the Tril-
ogy solution (Cell Marque) for 15 min in a pressure cooker. The sections were
then washed in PBS + Tween20 (PBST) and fixed for 1 hr in PBST with 10%
normal horse serum (NHS). They were incubated with Ki67 antibody (Table
S5) overnight at 4C in PBST with 5% NHS. After being washed in PBS, they
were incubated with the secondary antibody in PBS with 5% NHS. Sections
were then washed with PBS, stained with DAPI, and mounted. We identified
cells by using CellProfiler (http://www.cellprofiler.org) to count nuclei on the
DAPI channel, while Ki67 was scored manually in a blinded manner.
ACCESSION NUMBERS
The data for RNA and ChIP sequencing have been deposited in
NCBI’s Gene Expression Omnibus and are accessible through GEO Series
accession number GSE40594 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE40594).
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